Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Interdepartmental Center "Alma Mater Research Institute on Global Challenges and Climate Change (Alma Climate)", University of Bologna, Bologna, Italy.
Geroscience. 2021 Apr;43(2):985-1001. doi: 10.1007/s11357-020-00287-w. Epub 2020 Oct 31.
Fibroblast Growth Factor 21 (FGF21), Growth Differentiation Factor 15 (GDF15), and Humanin (HN) are mitochondrial stress-related mitokines, whose role in health and disease is still debated. In this study, we confirmed that their plasma levels are positively correlated with age in healthy subjects. However, when looking at patients with type 2 diabetes (T2D) or Alzheimer's disease (AD), two age-related diseases sharing a mitochondrial impairment, we found that GDF15 is elevated in T2D but not in AD and represents a risk factor for T2D complications, while FGF21 and HN are lower in AD but not in T2D. Moreover, FGF21 reaches the highest levels in centenarian' offspring, a model of successful aging. As a whole, these data indicate that (i) the adaptive mitokine response observed in healthy aging is lost in age-related diseases, (ii) a common expression pattern of mitokines does not emerge in T2D and AD, suggesting an unpredicted complexity and disease-specificity, and (iii) FGF21 emerges as a candidate marker of healthy aging.
成纤维细胞生长因子 21(FGF21)、生长分化因子 15(GDF15)和人源素(HN)是与线粒体应激相关的线粒体因子,其在健康和疾病中的作用仍存在争议。在这项研究中,我们证实它们的血浆水平与健康受试者的年龄呈正相关。然而,当观察到 2 型糖尿病(T2D)或阿尔茨海默病(AD)患者时,这两种与年龄相关的疾病都存在线粒体损伤,我们发现 GDF15 在 T2D 中升高而在 AD 中不升高,并且是 T2D 并发症的危险因素,而 FGF21 和 HN 在 AD 中降低而不在 T2D 中降低。此外,FGF21 在百岁老人的后代中达到最高水平,这是成功衰老的模型。总的来说,这些数据表明:(i)在健康衰老中观察到的适应性线粒体因子反应在与年龄相关的疾病中丧失;(ii)T2D 和 AD 中没有出现线粒体因子的共同表达模式,表明存在意外的复杂性和疾病特异性;(iii)FGF21 作为健康衰老的候选标志物出现。